IBI’s study is based on an Ingenix master research database that includes more than 1 million covered lives for 17 employers with up to three years of claims experience for medical, pharmacy, STD, LTD and workers’ compensation. From the sample, IBI analyzed the medication compliance and disability lost time for 5,483 employees with rheumatoid arthritis.